Previous reports showed that 7% to 15% of patients initially diagnosed with IPF were either MPO-ANCA-positive upon initial diagnosis or seroconverted during follow-up, and that approximately 25% of the MPO-ANCA-positive patients developed MPA [13, 14, 18]. This evidence concerns the gene MPO and idiopathic pulmonary fibrosis.